BillionToOne, Inc. (BLLN) vs Doximity, Inc. (DOCS)
A side-by-side comparison of BillionToOne, Inc. and Doximity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLLN
BillionToOne, Inc.
$100.42HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
DOCS
Doximity, Inc.
$28.43HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — BLLN vs DOCS
growth of $100 · dividends reinvested · last 1yBLLN +0.1% (+0.1%/yr)DOCS -54.3% (-54.3%/yr)BLLN compounded faster over this window
BLLN DOCS
BLLN vs DOCS: by the numbers
- •DOCS is the larger company ($5.32B vs $4.62B market cap).
- •DOCS trades at the lower trailing earnings multiple (33.44 vs 161.94 P/E), one valuation lens rather than an overall verdict.
- •DOCS converts more revenue to profit (25.48% vs 8.43% net margin).
Metrics side by side
Valuation
| Metric | BLLN | DOCS |
|---|---|---|
| P/E ratio | 161.94 | 33.44 |
| Forward P/E | 126.43 | 21.10 |
| PEG ratio | N/A | 0.64 |
| P/S ratio | 11.62 | 8.11 |
| P/B ratio | 8.60 | 5.80 |
| EV / EBITDA | 75.79 | 23.87 |
| FCF yield | 0.72% | 5.63% |
Profitability
| Metric | BLLN | DOCS |
|---|---|---|
| Gross margin | 71.27% | 88.07% |
| Operating margin | 10.90% | 29.60% |
| Net margin | 8.43% | 25.48% |
| ROE | 6.24% | 18.24% |
| ROIC | 6.39% | 15.35% |
Growth (annualized)
| Metric | BLLN | DOCS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 21.94% |
| EPS CAGR (5Y) | N/A | 54.32% |
| FCF CAGR (5Y) | N/A | 23.75% |
| Total return CAGR (5Y) | N/A | -18.23% |
Frequently asked
- Which has the lower trailing P/E, BLLN or DOCS?
- DOCS has the lower trailing P/E: BLLN trades at 161.94 and DOCS at 33.44. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is BLLN or DOCS more profitable?
- DOCS runs the higher net margin — BLLN at 8.43% versus DOCS at 25.48%.
Go deeper
Dig into the metrics
BillionToOne P/E ratioDoximity P/E ratioBillionToOne ROEDoximity ROEBillionToOne operating marginDoximity operating marginBillionToOne revenue growthDoximity revenue growthBillionToOne free cash flowDoximity free cash flow
BillionToOne & Doximity appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.